Expression of master regulatory genes of embryonic development in pancreatic tumors

L G Kondratyeva1, I P Chernov2, M V Zinovyeva2

  • 1Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russia. liakondratyeva@yandex.ru.

Insights

Pancreatic cancer development involves altered gene expression. Key developmental genes (SOX9, GATA4, PDX1, PTF1a, HNF1b) were downregulated, while KLF5 was upregulated in tumor cells, suggesting a critical role in neoplastic transformation.

Area of Science:

  • Oncology
  • Developmental Biology
  • Molecular Biology

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy.
  • Understanding the molecular mechanisms driving PDAC is crucial for therapeutic development.
  • Master regulators of embryonic pancreas development are implicated in cancer.

Purpose of the Study:

  • To investigate the expression levels of key embryonic pancreas developmental regulators in human pancreatic tumors.
  • To identify potential regulatory networks involved in pancreatic cancer initiation and progression.

Main Methods:

  • Quantitative analysis of gene expression in human pancreatic tumor samples versus normal pancreatic tissues.
  • Focus on transcription factors SOX9, GATA4, PDX1, PTF1a, HNF1b, and KLF5.

Main Results:

  • Significantly reduced expression of SOX9, GATA4, PDX1, PTF1a, and HNF1b in pancreatic tumor samples compared to normal tissues.
  • Elevated expression of KLF5 in pancreatic tumor cells.
  • Hypothesized that SOX9, GATA4, PDX1, PTF1a, and HNF1b form a regulatory module maintaining normal pancreatic cell identity.

Conclusions:

  • The coordinated downregulation of these developmental genes may be essential for the neoplastic transformation of pancreatic cells.
  • KLF5 may play a contrasting role in pancreatic tumorigenesis.
  • These findings highlight a potential regulatory network critical for pancreatic cancer development.